These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36271003)

  • 21. Mechanistic insights into transferable polymyxin resistance among gut bacteria.
    Xu Y; Lin J; Cui T; Srinivas S; Feng Y
    J Biol Chem; 2018 Mar; 293(12):4350-4365. PubMed ID: 29462787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of a polymyxin derivative for photolabeling studies in the gram-negative bacterium Escherichia coli.
    van der Meijden B; Robinson JA
    J Pept Sci; 2015 Mar; 21(3):231-5. PubMed ID: 25640745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outer Membranes of Polymyxin-Resistant
    Jiang X; Yang K; Han ML; Yuan B; Li J; Gong B; Velkov T; Schreiber F; Wang L; Li J
    ACS Infect Dis; 2020 Oct; 6(10):2698-2708. PubMed ID: 32871077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
    Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
    Elife; 2021 Apr; 10():. PubMed ID: 33821795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causes of polymyxin treatment failure and new derivatives to fill the gap.
    Chiu S; Hancock AM; Schofner BW; Sniezek KJ; Soto-Echevarria N; Leon G; Sivaloganathan DM; Wan X; Brynildsen MP
    J Antibiot (Tokyo); 2022 Nov; 75(11):593-609. PubMed ID: 36123537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.
    Gilleland HE; Farley LB
    Can J Microbiol; 1982 Jul; 28(7):830-40. PubMed ID: 6293694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electron microscopic observations of polysaccharide components in polymyxin B treated outer membranes from Serratia marcescens.
    Weber DA; Nadakavukaren MJ; Tsang JC
    J Antibiot (Tokyo); 1979 Jan; 32(1):66-72. PubMed ID: 83989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modification of outer membrane permeability and alteration of LPS in veterinary enterotoxigenic Escherichia coli.
    Davin-Regli A; Guerin-Faublée V; Pagès JM
    Res Vet Sci; 2019 Jun; 124():321-327. PubMed ID: 31035220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B.
    Rosenthal KS; Storm DR
    J Antibiot (Tokyo); 1977 Dec; 30(12):1087-92. PubMed ID: 202585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymyxin-resistant clinical isolates of Escherichia coli.
    Urban C; Tiruvury H; Mariano N; Colon-Urban R; Rahal JJ
    Antimicrob Agents Chemother; 2011 Jan; 55(1):388-9. PubMed ID: 21041507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.
    From AH; Fong JS; Good RA
    Infect Immun; 1979 Mar; 23(3):660-4. PubMed ID: 222676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent reduction of lipopolysaccharide pyrogenicity by polymyxin B.
    Warner SJ; Mitchell D; Savage N; McClain E
    Biochem Pharmacol; 1985 Nov; 34(22):3995-8. PubMed ID: 2998395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium deoxycholate sulfate on outer membrane permeability and neutralization of bacterial lipopolysaccharides by polymyxin B formulations.
    Madhumanchi S; Suedee R; Kaewpiboon S; Srichana T; Khalil R; Ul-Haq Z
    Int J Pharm; 2020 May; 581():119265. PubMed ID: 32217155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel derivatives of polymyxins.
    Vaara M
    J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.
    Cooperstock M; Riegle L
    Infect Immun; 1981 Jul; 33(1):315-8. PubMed ID: 6266967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of polymyxin resistance through the food chain, the global crisis.
    Ray M; Manjunath A; Halami PM
    J Antibiot (Tokyo); 2022 Apr; 75(4):185-198. PubMed ID: 35079146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility.
    Paracini N; Clifton LA; Skoda MWA; Lakey JH
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7587-E7594. PubMed ID: 30037998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel decoy strategy for polymyxin resistance in
    Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
    Elife; 2021 Jun; 10():. PubMed ID: 34180396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane-disorganizing property of polymyxin B nonapeptide.
    Lam C; Hildebrandt J; Schütze E; Wenzel AF
    J Antimicrob Chemother; 1986 Jul; 18(1):9-15. PubMed ID: 3019982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.